Population Pharmacokinetics (PopPK) of Quizartinib and Its Active Metabolite AC886 in Patients (Pts) With Newly Diagnosed (ND) Acute Myeloid Leukemia (AML)

Oncology

MIDD

Regulatory interactions

Pharmacometrics

Vaddady P, Smania G, Glatard A, Nakayama S, Inoue H, Kurumaddali A, Abutarif M, Sheng M